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Glycosaminoglycans (GAGs) and GAG-degrading enzymes
have wide-ranging applications in the medical and biotechno-
logical industries. The former are also an important nutrient
source for select species of the human gut microbiota (HGM), a
key player in host–microbial interactions. How GAGs are
metabolized by the HGM is therefore of interest and has been
extensively investigated in the model human gut microbe Bac-
teroides thetaiotaomicron. The presence of as-yet uncharacter-
ized GAG-inducible genes in its genome and of related species,
however, is testament to our incomplete understanding of this
process.Nevertheless, it presents a potential opportunity for the
discovery of additional GAG-degrading enzymes. Here, we
investigated a gene of unknown function (BT_3328) from the
chondroitin sulfate (CS) utilization locus of B. thetaiotaomi-
cron. NMRandUV spectroscopic assays revealed that it encodes
a novel polysaccharide lyase (PL), hereafter referred to as
BtCDH, reflecting its source (B. thetaiotaomicron (Bt)) and its
ability to degrade theGAGsCS, dermatan sulfate (DS), and hya-
luronic acid (HA).When incubated with HA, BtCDH generated
a series of unsaturated HA sugars, including 4,5UA-GlcNAc,
4,5UA-GlcNAc-GlcA-GlcNac, 4,5UA-[GlcNAc-GlcA]2-GlcNac,
and 4,5UA-[GlcNAc-GlcA]3-GlcNac, as end products and
hence was classed as endo-acting. A combination of genetic and
biochemical assays revealed that BtCDH localizes to the cell sur-
face of B. thetaiotaomicron where it enables extracellular GAG
degradation. BtCDH homologs were also detected in several
other HGM species, and we therefore propose that it represents
the founding member of a new polysaccharide lyase family
(PL29). The current discovery also contributes new insights into
CS metabolism by the HGM.
Mammalian glycosaminoglycans (GAGs)2 are complex car-
bohydrates consisting of repeating disaccharide units of uronic
acids or galactose linked to a hexosamine sugar (1, 2). These
include chondroitin sulfate (CS) made up of GlcA andGalNAc,
dermatan sulfate (DS), or chondroitin sulfate B made up of
IdoA and GalNAc, hyaluronic acid (HA) made up of GlcA and
GlcNAc, heparin/heparan sulfate (HS) made up of a mixture of
GlcA and IdoA linked to GlcNAc and keratan sulfate made up
of galactose linked to GlcNAc. GAGs such as CS, DS, and HS
are also characterized by highly diverse sulfation patterns
(introduced during biosynthesis by specific sulfotransferase
enzymes) that define variousmolecular subtypes of each glycan
(3, 4). CS, for example, can be sulfated on GalNAc at different
positions including C4, C6, or both to yield major CS subtypes
namely CSA, CSC, and CSE, respectively (5, 6) or at both C2 of
GlcA and C6 of GalNAc, yielding CSD (7). In contrast, HA is
not sulfated andhence less structurally complex comparedwith
the other GAG types.
GAGs are ubiquitously distributed in the human body and
implicated in several important physiological processes such as
cell signaling, inflammation, neuronal development, adhesion,
and tumor progression (8–11). Dietary GAGs are also a nutri-
ent source for the human gut microbiota (HGM), which is
known to impact greatly on human health and disease status
(12–17). Indeed, recent evidence suggests that CS is a priority
nutrient for prominent gut microbes such as Bacteroides
thetaiotaomicron and Bacteroides ovatus and that only a subset
of HGM species are capable of metabolizing the GAG (13, 15,
17). Understanding howGAGs aremetabolized could therefore
inform strategies including nutrient-based approaches to
manipulate theHGMand hence improve human health. In line
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with this, several studies (reviewed by Ndeh and Gilbert (18))
have examined the metabolism of dietary GAGs by the HGM.
The results demonstrate that GAG degradation is largely
orchestrated by a combination of three major enzyme types
including polysaccharide lyases (PLs, EC 4.2.2.-), sulfatases (EC
3.1.6.-), and glycoside hydrolases (EC 3.2.1.-). In the model
human gut microbe B. thetaiotaomicron, as well as other gut
Bacteroidetes, the genes encoding these enzymes are typically
located within polysaccharide utilization loci (PULs) (14,
19–21). These genetic loci are diverse and encode a variety of
cell envelope–associated multiprotein systems involved in
complex glycan metabolism. Although the mechanisms of var-
iousGAGPULs in these organismshave been extensively inves-
tigated, knowledge of their functioning is incomplete, evident
by the presence of as-yet uncharacterized GAG-inducible
genes within these PULs (21). In the CS PUL of B. thetaiotao-
micron, three of such genes, BT_3328, BT_3329, and BT_3330
(all of unknown function), appear in a distinct operon
(BT_3328–30) conserved in several HGM Bacteroidetes (14,
20, 21). The latter suggests that they might be an important
adaptation for CS metabolism in these microbes. Here, we
characterized the largest member of this operon (BT_3328),
revealing that it encodes a novel polysaccharide lyase hereafter
referred to as BtCDH, reflecting its source (B. thetaiotaomicron
(Bt)) and ability to degrade the GAGs CS, DS, and HA. We
also provide evidence suggesting that BtCDH is not only the
foundingmember of a novel enzyme family but also a cell surface
GAG-degrading enzyme, the first to be reported in B. thetaiotao-
micron and related species. Taken together, our findings contrib-
ute new insights into our knowledge of CS metabolism by the
HGM, a key player in host–microbial interactions.
Results
In silico data on native BtCDH lyase
The gene encoding native BtCDH lyase (BT_3328 from
B. thetaiotaomicron VPI-5482) is 2607 bp in length and has a
GC content of 51%. BtCDH is a large protein of 868 amino acid
residues, a molecular mass of 96 kDa, and an isoelectric pI of
5.33. Amajority of the top hits (50% identity) from a BLASTp
search with native BtCDH are hypothetical/putative uncharac-
terized proteins mainly annotated as DUF4955 domain–
containing. The DUF4955 domain whose function is unknown
is present at the C terminus of the protein, whereas another
domain DUF4988 is located directly after the putative lipopro-
tein signal peptide sequence at the N terminus of the protein
(Fig. 1A). Top BtCDH lyase homologs were mostly detected in
species from the Bacteroides, Alistipes, and Prevotella genera,
all highly represented in the HGM. They were also prominent
in species from marine environments including Saccharopha-
gus degradans, Zobellia galactinovorans, Vibrio harveyi, and
Coraliomargarita akajimensis. A phylogenetic tree of selected
homologs of BtCDH is presented in Fig. 1B.
Activity of BtCDH
Purified recombinant BtCDH was initially assayed spectro-
photometrically using CS from bovine trachea (which is mainly
CS-4 sulfate or CSA (22)) (Fig. 2A) as substrate. BtCDH
degraded CSA generating unsaturated products that were
detected by TLC and high-performance anion-exchange chro-
matography (HPAEC) using a UV detector at 235 nm (A235)
(Fig. 2, B and C, respectively). Limit products of the reaction
were also resolved by size-exclusion chromatography (SEC)
and analyzed by 1H NMR (Fig. 2D and Fig. S1). Distinct reso-
nance signals were detected at 5.9 and 5.2 ppm in the spectra of
the digested products as opposed to undigested CSA. The for-
mer is evidence of a H4 proton chemical shift consistent with
glyosidic bond cleavage and the generation of C4,5 double
bonds (4,5) in the terminal nonreducing end GlcA or uronic
acid (UA) residue (4,5UA) of various products, whereas the
latter peak at 5.2 ppm corresponds to resonance signals of the
H1 anomeric proton of the same sugar (Fig. 2D) (23–26).
To explore the substrate specificity in BtCDH inmore detail,
the enzyme was also tested against a series of commercially
available uronic acid-based substrates including CS from shark
cartilage (mainly CS-6 sulfate or CSC), DS from porcine intes-
tinal mucosa (mainly DS-4 sulfate), high and low molecular
weightHA sodium salt from Streptococcus equi (10,000–30,000
(HAL) and 90,000–110,000 Da (HAH), respectively), heparin,
alginate, ulvan, and polygalacturonic acid. BtCDH was active
against CS DS and HA (in the order CSC CSA/HALDS
HAH) but not heparin, alginate, ulvan, and polygalacturonic
acid (Table 1). Previous studies analyzing CSA and CSC have
reportedmajor differences in the sulfated disaccharide compo-
sition of both substrates with the most prominent being the
levels of the UA-GalNAc4S, which is higher in CSA, and
UA-GalNAc6S, which is higher in CSC (12, 22, 27, 28).
BtCDH activity thus appears to be affected by the type of sulfa-
tion in the GAG substrates.
Degradation pattern and mode of BtCDH lyase activity
To determine whether BtCDH was endo- or exo-acting, we
performed time-course experiments with HAL, a less chemi-
cally complex GAG compared with its sulfated counterparts.
HAL was incubated with BtCDH over different times (0, 1, 5,
and 60 min and 12 h (overnight), after which reactions were
stopped by boiling and analyzed byTLC. BtCDHdegradedHAL
within 10 min, generating a fast migrating band (band A) (Fig.
3A). After 1 h of the reaction, the original HAL spot at the origin
disappeared accompanied by the appearance another major
band (band B), as well as low staining intermittent bands (Fig.
3A). The pattern of products remained unchanged even after
overnight digestion, and hence the generated sugars repre-
sented the final limit products of HAL digestion. Bands A and B
limit products were purified by SEC and analyzed by MS
(HILICLC-MS). Purified BandA yielded incrementalmasses of
380.117, 381.120, and 382.123 Da (differing by a mass of 1 Da)
equivalent to themass of singly charged ions of the unsaturated
4,5UA-GlcNAc disaccharide, whereas band B yielded incre-
mentalmasses of 759.227, 759.729, and 760.230Da (differing by
amass of 0.5 Da) etc. (Fig. 3B), equivalent to themass of doubly
charged fragments derived from the unsaturated 4,5UA-
[GlcNAc-GlcA]3-GlcNAc octasaccharide parent ion. To detect
underrepresented sugars, all SEC fractions were pooled in one
sample and analyzed. The spectra revealed the presence of new
products with incremental masses of 759.226, 760.230, and
761.232 (differing by a mass of 1 Da) and 1138.337, 1139.340,
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and 1140.344 (differing by a mass of 1 Da), corresponding to
singly charged ions of the unsaturated 4,5UA-GlcNAc-GlcA-
GlcNAc tetrasaccharide and 4,5UA-[GlcNAc-GlcA]2-GlcNAc
hexasaccharide sugars, respectively (Fig. 3B). The generation of
diverse molecular weight limit products thus suggests that
BtCDH is an endo-acting enzyme. In addition, the accumula-
tion of the high molecular weight HA octasaccharide suggests
thatBtCDHpreferentially cleaves sugarswithadegreeofpolymer-
ization (DP) typically10. The requirement for substrates with a
DP  10 was also demonstrated using sulfated CS oligosaccha-
rides as substrates with HPAEC data showing a major shift in the
DP10oligosaccharide profile (as opposed to aminor shift forDP8)
after treatment with BtCDH (Fig. 4). The proportion of each HA
product generated was also determined by UV with the results
showing that over 70% of the generated products were 4,5UA-
GlcNAc disaccharides (Fig. S2). Time-course experiments with
sulfated GAGs CSA and CSC as substrates also yielded fairly sim-
ilar patterns observed for HAL (Fig. S3). As with HAL, high
amounts of the basic disaccharide building block (4,5UA-Gal-
NAc) were detected, suggesting high processivity in the enzyme.
Impact of temperature, pH, and metals on BtCDH
The effects of temperature, pH and metal ions on BtCDH
activity were tested with CSA as substrate. BtCDH preferred
higher reaction temperatures with the activity increasing lin-
early from 20 °C to a maximum rate of 15 M/min at 60 °C
(Fig. 5A). After this optimum temperature, the enzyme activity
dropped sharply. To determine the optimum pH of BtCDH,
enzyme activity was examined against CSA in different buffers
over a pH range of 4–9. BtCDH activity rose gradually with
increase pH between 4 and 6 and then sharply to an optimum
pHof 7.0 in 10mMMES buffer (Fig. 5B). BtCDHactivity against
CS was also tested in the presence of 5 mM EDTA and metal
ions including Mg2, Ca2, Mn2, Co2, Zn2, and Ni2. Its
Figure 1. Modular architecture of native BtCDH and phylogenetic analyses. A, BtCDH (GenBankTM accession number AAO78434) contains an N-terminal
lipoprotein signal peptide sequence (SP) and a large central region sandwiched by two domains of unknown function (DUF4988 and DUF4955). B, phyloge-
netic tree showing the distribution of BtCDH homologs in selected species from various environments.
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activity was only slightly affected by metals with the most inhi-
bition (27.42%) observed in the presence of Co2 ions (Fig. 5C).
Growth experiments
A genetic mutant BtCDH lacking the entire ORF for BtCDH
(the BT_3328 gene) was created by counter selectable allelic
exchange. Growth experiments with both B. thetaiotaomicron
WT and BtCDH strains were carried out with four different
GAG substrates CSA, DS, CSC, HAL, and glucose as sole carbon
source for at least 24 h. B. thetaiotaomicron WTand BtCDH cells
grew at a very similar rates on various substrates, except for CSC
where a minor defect in late phase growth was observed (Fig. S4).
Figure 2. Analyses of chondroitin 4-sulfate (CSA) degradationbyBtCDH lyase.A, chemical structure of intact CSA. B, TLC of CSA before and after digestion
by BtCDH lyase. For the reaction, 13.3 mg/ml of CSA from bovine trachea was treated with 0.3M of BtCDH lyase overnight. The reaction was stopped by boiling
and 53.4 g of digested CSA analyzed by TLC. Lane 1, CSA; lane 2, CSA treated with BtCDH lyase. C, HPAEC chromatogram of CSA digestion. Half the amount
(26.7 g) of sample in A was analyzed by HPAEC. D, 1H NMR results of CSA digestion by BtCDH lyase. Digested CSA products were purified by SEC and later
analyzed by NMR. Panel 1, NMR spectrum of undigested CSA. Panel 2, spectra of species from all SEC fractions combined (fractions 1– 43 in Fig. S1). Panel 3,
spectra of species from selected homogenous fractions (pooled fractions 37–39 in in Fig. S1). Both spectra show resonance peaks for H1 and H4 (black and red)
at 5.1 and 5.9 ppm, respectively, consistent with the formation of terminal unsaturated CSA oligosaccharides. Panel 4 (inset), a typical chemical rearrangement
of components of the nonreducing end sugar in CSA after lyase digestion. H4 and H1 are marked with red and black circles, respectively.
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Polyclonal antibodies and cellular localization assays
Polyclonal antibodies to BtCDH detect two forms of the
protein—Rabbit anti-BtCDH polyclonal antibodies where gen-
erated using the recombinant BtCDH protein as immunogen.
OnWestern blots containing cell-free extracts of B. thetaiotao-
micron grown on CSA, two immunosensitive bands (BtCDHH
and BtCDHL of high and low molecular weights, respectively)
were detected (Fig. 6A). Despite its poor enrichment relative to
BtCDHL, BtCDHH’smolecular weight was close to 96 kDa, cor-
responding to the mass of native BtCDH, whereas the mass of
BtCDHL was 30 kDa. Interestingly, when cell extracts of the
BtCDH strain lacking BtCDHwere tested with the same anti-
bodies, both bands were not detected, suggesting that BtCDHL
is a subcomponent possibly a truncated form of BtCDH (Fig.
6A, top panel). To confirm this, BtCDH was FLAG-tagged
(BtCDH FLAG) by genetically introducing a FLAG peptide
sequence (DYKDDDK) at the C-terminal of the protein, thus
allowing for its detection using rabbit anti-FLAG specific anti-
Table 1
Activity of BtCDH lyase against various uronate substrates
Figure 3. Evidence of BtCDH endo-lyase activity. A, TLC showing progressive degradation of hyaluronanic acid (HAL, 10 –20 kDa) by BtCDH lyase over time.
For the reaction, 32 mg/ml of HAL was digested with 2M of enzyme. The reaction was stopped at the various time points indicated, and 64g of each sample
was analyzed by TLC. B, mass spectrometry data of purified HAL oligosaccharide species. Panel 1, spectrum for
4,5UA-disaccharide (4,5UA-Di or band A). Panel
2, spectrum for 4,5UA-octasaccharide (4,5UA-Octa or band B). Panel 3, spectrum for 4,5UA-tetrasaccharide (4,5UA-Tetra). Panel 4, spectrum for 4,5UA-
hexasaccharide (4,5UA-Hexa). C, structural representation of various species detected in B.
A novel glycosaminoglycan-degrading enzyme family (PL29)
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bodies. Under these circumstances, only BtCDHHwas detected
by immunoblotting (Fig. 6A), suggesting that BtCDHL was an
N-terminal truncated version of BtCDH.
Proteinase K, immunofluorescence, and whole-cell assays—
As indicated earlier, BtCDH contains an N-terminal lipidation
sequence (Fig. 1A) and hence is potentially localized extracel-
lularly at the cell surface of B. thetaiotaomicron. To confirm
this experimentally, we performed proteinase K (PK) and im-
munofluorescence assays. B. thetaiotaomicron WT cells were
grown to exponential phase in 1% CSA, harvested, and treated
with 0.5 mg/ml PK. Treated and untreated cells (controls) were
lysed under reducing conditions, and cell extracts were ana-
lyzed by Western blotting using anti-BtCDH antibodies. The
results showed degradation of BtCDHL and BtCDHH in PK-
treated but not control cells (Fig. 6B). The experiment was
also controlled by immunoblotting the same extracts with
polyclonal antibodies targeting the constitutively expressed
periplasmic heparin lyase BT4657 (16) whose bands remained
intact in test and control extracts (Fig. 6B). The data thus sug-
gest that BtCDH is localized to cell surface of B. thetaiotaomi-
cron. The cell-surface localization of BtCDH was finally con-
firmed through immunofluorescence assays using anti-BtCDH
antibodies (Fig. 6C). We also performed whole-cell aerobic
assays on B. thetaiotaomicron WT and BtCDH following
growth on CSA. Under these conditions, transport across the
outer membrane is limited, and only surface enzyme activity is
detected. The cells were harvested at exponential phase and
reincubated with CSA and CSC for 2 h, and the reaction was
examined by TLC. The results showed extensive degradation of
both CSA and CSC by the WT strain, visible as a smear of
products (Fig. 6D). This was significantly reduced in the knock-
out strain especially for the CSA substrate in which just a single
band of generated product was observed (Fig. 6D). Superna-
tants at exponential phase were also analyzed for secreted
BtCDHbyWestern blottingwith polyclonal rabbit anti-BtCDH
antibodies, but only a faint band of the truncated form BtCDHL
was detected (Fig. S5). Finally culture supernatants from
B. thetaiotaomicron WT and BtCDH at exponential phase
were tested for secreted activity, but the TLC profiles of the
treated and untreated CS substrates were very similar, except
for a major band initially present in the supernatants (Fig. S5).
We thus conclude that BtCDH activity is mainly present at the
cell surface of B. thetaiotaomicron.
Discussion
In this study, we discovered and characterized the founding
member of a novel family of GAG lyases from the prominent
gut bacterium B. thetaiotaomicron. BtCDH is encoded by a
gene from an operon (BT3328–30) of unknown function
within the CS PUL of B. thetaiotaomicron (14), and hence until
now, its function was unknown.We show that BtCDH exhibits
polysaccharide lyase activity toward a variety of GAGs
substrates including CS, DS, and HA. BtCDH alongside pre-
viously characterized CS ABC lyases from B. thetaiotaomi-
cron WAL2926 (BactnABC) (22) and Proteus vulgaris (ChS
ABC lyase I andChSABC lyase II) (29), named after their ability
to degrade CSA, DS or CSB and CSC, are the only few lyases
known to exhibit such broad GAG substrate specificity.
BtCDH, however, displays very low catalytic efficiency (based
on kcat/Km values) when compared with both enzymes. Bacte-
roides stercoris, Pedobacter saltans, Flavobacterium hepari-
num, and Vibrio sp. FC509 CS AC lyases degrade a variety of
GAGs but are unable to degrade DS (2, 23, 30, 31), whereas
B. stercoris ABC and F. heparinum ABC lyases, which are capa-
ble of degrading DS and CS, are unable to degrade HA (2). We
also show, usingHA as substrate, that BtCDHexhibits an endo-
mode of activity, preferentially targeting oligosaccharides with
DP 10. It may be possible that BtCDH contains over 10 sub-
sites in its active site; however, further 3D structural studies of
the enzyme in complex with the substrate (for which attempts
weremade in this study but were unsuccessful) will be required
to determine this.
The enzyme also showed optimum activity at a very high
temperature of 60 °C, contrary to most PLs with optimum
temperatures between 30 and 40 °C (2, 22, 23, 29, 31). A notable
Figure 4. Activity of BtCDH against various chondroitin sulfate oligosac-
charides. Substrates (1 mg/ml each) were treated with 0.5 M of BtCDH
(shown as DPx, with x being the number of constituent monosaccharides)
overnight or diluted in equivalent volume of buffer as control (DPx). HPAEC
chromatograms show major shifts in the signals of sulfated DP10 and DP12
oligosaccharides following treatment, accompanied by the appearance of a
strong signals for the 4,5UA-GalNAc disaccharide in each case.
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exception is the ScPL8H lyase from Streptomyces coelicolor A3
(a nonpathogenic filamentous soil bacterium)with an optimum
temperature of 57 °C (32). BtCDH activity was also only slightly
affected by EDTA and the divalent metal ions tested in this
study. Although it is possible that a metal ion inaccessible to
EDTA chelation may be present and directly or indirectly
involved in enzyme activity, the low sensitivity to diverse met-
als, broad CS substrate specificity, and thermophilic nature of
BtCDH make it an attractive target from a biotechnological
perspective. It is also worth noting that of the 28 PL families
known to date, only 3 contain CS lyases (33), and hence BtCDH
and its family members make an important addition to this
group of enzymes in terms of the diversity of enzymatic options
available for CS related investigations. The current family has
now been designated polysaccharide lyase family 29 (PL29). Its
presence in species from diverse environments including soil
andmarine bacteria also suggests that it may serve as an impor-
tant adaptation for CS metabolism in these environments.
Another major finding in our study was the extracellular
localization of BtCDH in B. thetaiotaomicron. The significance
of this discovery lies in the fact that until now, models of CS
metabolism did not include extracellular cell surface degrada-
tion of the substrate because no such enzymes had been
reported in this organism before. In recent reports by Raghavan
and Groisman (14) and Raghavan et al. (20), extracellular CS
is bound and directly transported by a SusCD-like complex
(BT3331–3332) into the periplasmic space without any initial
extracellular cleavage. Hence to date, general consensus has
held that enzymatic CS degradation begins in the periplasmic
space of B. thetaiotaomicron. We not only present evidence of
the extracellular localization of BtCDH but show through
whole-cell assays that B. thetaiotaomicron is capable, with the
Figure 5. Effect of temperature and pH andmetals on BtCDH lyase activity. A, effect of temperature. Enzymatic activity was measured using 40M of CSA
as substrate in 20 mM NaH2PO4 at pH 7.0 over different temperatures. B, effect of pH. BtCDH activity was measured at different pH levels using 20 mM of various
buffers at 37 °C. C, effect of various metals. The reactions were carried out in 20 mM NaH2PO4 buffer containing 5 mM EDTA, Mg
2, Ca2, Mn2, and Co2 and
1 mM Zn2 and Ni2 in separate experiments.
Figure 6. Localization of BtCDH and evidence of extracellular chondroitin lyase activity. A, Western blots showing the detection of full and truncated
versions of BtCDH (BtCDHH and BtCDHL, respectively) inB. thetaiotaomicronWT,BtCDH, and BtCDH FLAG cell extracts using polyclonal rabbit anti-BtCDH (top
panel) and anti-FLAG tag antibodies (bottompanel).B, Western blotting analyses of proteinase K–treated and control cells using anti-BtCDH antibodies. The top
results show loss of BtCDHH and BtCDHL after the treatment of whole cells with proteinase K. Thebottom results show detection of an intact periplasmic control
protein, the BT4657 heparinase of B. thetaiotaomicron (16). C, immunofluorescence detection of BtCDH in B. thetaiotaomicron WT and BtCDH cells. The top
panel shows green fluorescence signals of BtCDH. The middle panel shows blue signals from stained nuclei. The bottom panel is a merger of both signals. D,
evidence of extracellular CS degradation in B. thetaiotaomicron by TLC. Top gel, TLC analyses of CS degradation when whole cells of B. thetaiotaomicron WT,
BtCDH, and BtCDH FLAG are incubated with CSA.Bottomgel, TLC analyses of CS degradation when whole cells ofB. thetaiotaomicronWT,BtCDH, and BtCDH
FLAG are incubated with CSC.
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aid of BtCDH of degrading CS extracellularly. Although our
growth data did not show a significant defect in the ability of
B. thetaiotaomicron to utilize most of the GAG substrates dur-
ing growth, extracellular substrate degradation in a complex
polymicrobial setting like the HGM could have significant
implications for competition or cooperation between HGM
species and hence microbial community structure. We also
observed that the absence of BtCDH did not completely pre-
vent extracellular degradation of CS in whole-cell assays, sug-
gesting the presence of other unknown surface CS-degrading
enzymes. This was more pronounced in whole-cell assays
involving CSC where the mutant strain still showed significant
CS degradation comparedwith theWT.Nevertheless, based on
the evidence thus far for BtCDH, we propose a modification of
the current model for CSmetabolism in B. thetaiotaomicron to
include the extracellular CS degrading activity encoded by
BtCDH(Fig. 7). In thismodel, a complexly sulfatedCS substrate
such as CSC with a high degree of polymerization (DP 10) is
initially cleaved on the cell surface generating oligosaccharides
that are then bound and transported into the periplasmic space
for further degradation by periplasmic enzymes as previously
described (12, 14, 34) (also see Fig. 7). In future studies, we will
also investigate thepossibility that extracellularCSoligosaccha-
rides generated by BtCDH, e.g. in the case of CSA, are the basis
of cross-feeding and interbacterial interactions that may influ-
ence host health. To conclude, our current findings not only
satisfy the growing demand for novel biocatalysts for modern
biotechnological and medical research applications but also
contribute new insights relevant to our understanding of CS or
complex glycan metabolism by the HGM, a key player in host–
microbial interactions.
Materials andmethods
Plasmid construction and heterologous protein expression
The full-length BtCDH gene lacking the N-terminal lipopro-
tein signal sequence was amplified by PCR from B. thetaiotao-
micron VPI-5482 genomic DNA using primers (BtCDHF,
CGCGGGATCCgacgaacgggatgatctg; and BtCDHR, CGCGC-
TCGAGttatttaagtgcgttgagccatc) containing BamHI and XhoI
restriction sites, respectively. The gene was cloned into pET-
28a () vector (Novagen) which introduces a C-terminal His6
tag. For this, Escherichia coli TOP10 cells (Thermo Fisher Sci-
entific) were used. The recombinant construct was sequenced
Figure7. ProposedmodelofCSmetabolismshowing the contextofBtCDHactivity.BtCDH orchestrates extracellular degradation of sulfated CS (DP10)
to generate oligosaccharide products that are imported through an outer membrane protein complex (encoded by BT_3331 and BT_3332 genes) into the
periplasmic space. They are further degraded by periplasmic sulfatases, lyases, and unsaturated glycoside hydrolase enzymes yielding end products 5-keto,
4-deoxyuronate, and GalNAc, which can be metabolized to provide energy for cell growth. Disaccharide intermediates generated during the process serve as
signaling molecules activating expression of locus genes through binding to a hybrid two-component sensor protein (encoded by BT_3334) when CS is
present.
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(Eurofins Genomics) and later used to transform E. coli BL21
(DE3) expression cells (Thermo Fisher Scientific). The cells
were cultured in Luria–Bertani medium containing 10 g/ml
kanamycin antibiotic to mid-log phase (A600 of 0.6). Protein
expression was induced by adding 0.01 mM isopropyl -D-1-
thiogalactopyranoside to cells followed by growth overnight at
16 °C. The next day, the cells were harvested by centrifugation
(4000 g) and resuspended in Talon buffer (20 mM Tris/HCl,
pH 8.0, plus 100 mM NaCl). The cells were then disrupted and
centrifuged (16,000  g) for 20 min at 4 °C. BtCDH was then
purified from the resulting cell-free extract by immobilized
metal affinity chromatography using fresh Talon resins (Clon-
tech Laboratories Inc.). In the process, the CFE was loaded in a
column containing theTalon resin and later washedwithTalon
buffer. Another wash was performed with Talon buffer con-
taining 10 mM imidazole followed by recombinant protein elu-
tion with 100mM imidazole. Purified proteins were analyzed by
SDS-PAGE (12.5% gels) under reducing conditions. The analy-
ses revealed a major protein band of96 kDa, consistent with
the predicted size of BtCDH. The samples were pooled, and
buffer was exchanged into 20 mM NaH2PO4 buffer, pH 7.0, or
other buffers of choice depending on the intended use.
Enzyme assays and biochemical properties of BtCDH
Activity assays against various GAGs were performed at
37 °C in 20 mM sodium phosphate buffer, pH 7.0. The final
reaction volume was 600 l containing 10 nM of enzyme in all
cases except HA (containing 40 nM of enzyme) and varying
concentrations of the substrate. The reactions were monitored
using a Ultrospec 4000, UV-visible spectrophotometer at A235.
To determine the optimum temperature of BtCDH activity, 40
M of CSA was digested with 10 nM of BtCDH at different
temperatures, and the activity was monitored. To determine
the optimum pH, the same reaction was performed at different
pH levels with 20 mM of each buffer. For metal dependence
assays, various metals (5 mM for Mg2, Ca2, Mn2, and Co2
and 1 mM for Zn2 and Ni2), as well as EDTA (5 mM), were
included in separate reactions, and their effects on enzyme
activity were tested.
Thin-layer chromatography
Enzymatic reactions were stopped by heating at 98 °C for 3
min and later centrifuged at 16,000 g for 1min. Each reaction
(2-l drops) was spotted onto a Silicagel 60 TLC plate (Merck),
and the components were resolved in a mobile phase contain-
ing butanol/acetic acid/water (2:1:1, v/v/v). The plates were
later dried and developed with orcinol–sulfuric acid reagent
(containing 0.1% orcinol and sulfuric acid, ethanol, water in the
ratio 3.2:75:21.5 v/v/v). To visualize the sugar bands, the plates
were gently warmed near a Bunsen flame.
SEC of polysaccharides
Samples (5ml) were resolved using a Bio-Gel P2 size-exclu-
sion gels packed in Econo-Column chromatography columns
(Bio-Rad). The mobile phase was 50 mM acetic acid, and the
pump flow rate was set at 0.2 mlmin1. For small scale (200l)
purifications, elution was achieved by gravity. Fractions were
later analyzed by TLC.
NMR
Digested products of CSA from bovine trachea were sepa-
rated by SEC on a Bio-Gel P2 size-exclusion system (Bio-Rad),
and fractions were analyzed by TLC as described above. Puri-
fied fractions were collected and freeze-dried at50 °C using a
CHRIST Gefriertrocknung ALPHA 1–2 (Helmholtz-Zentrum)
freeze-dryer. The samples were redissolved in 0.7 ml of deute-
rium oxide (99.9 atom % D) for NMR analyses. NMR spectra
were obtained on a Bruker Avance III HD 700 MHz NMR
spectrometer equipped with a TCI cryoprobe. Spectra were
acquired at 298 K and were referenced to trimethylsilylpro-
panoic acid (TSP).
High-performance anion-exchange chromatography
HPAEC analyses were carried out using an automated
Dionex ICS3000 system (Dionex) fitted with Spherisorb-
SAX columns and linked to an AD25 absorbance detector
(Dionex). For HA samples, DionexTM CarboPacTM PA1 col-
umns (Dionex) were used. The mobile phase consisted of 3 M
NaCl applied as a 0–100%gradient over 110min. The datawere
analyzed using the ChromeleonTM chromatography software
(version 6.8) (Dionex).
BtCDH deletion mutant and FLAG tagging
BtCDH and BtCDH FLAG strains were generated through
counter-selectable allelic exchange using the pExchange vector
as described by Koropatkin et al. (35).
Growth of B. thetaiotaomicron WT and mutant strains
B. thetaiotaomicron WT, BtCDH, and BtCDH FLAG
strains were cultured in 5 ml of TYG (tryptone–yeast extract–
glucose)medium at 37 °C in an anaerobic cabinet (Whitley A35
work station; Don Whitley). The next day 10 l of cells were
added to 200 l of minimal medium (38) containing 1% of var-
ious GAGs plus 1.2 mg/ml porcine hematin (Sigma–Aldrich).
Cell growth was monitored at A600 using a Gen5 v2.0 micro-
plate reader (Biotek).
Proteinase K experiments
The experiments were performed as described byNdeh et al.
(36) with the following modifications: 1) B. thetaiotaomicron
WTcells were grown in 5ml ofminimalmediumcontaining 1%
CSA from bovine trachea to exponential phase (A600 of 0.8).
Final cell pellets were dissolved in 300l of Laemmli buffer, and
the samples were heated for 3 min. For each sample, 10 l was
analyzed by SDS-PAGE (7.5%). Immunoblotting was per-
formed with rabbit anti-BtCDH antibodies at a 1:5000 dilution.
For BtCDH FLAG cells, a 1:2000 dilution of rabbit anti-FLAG
antibodies was used. In all cases, secondary antibodies were
goat anti-rabbit IgG antibody, and (HL) HRP conjugate
(Invitrogen) at a 1:4000 dilution. The signals were developed
using ClarityTM Western ECL substrate (Bio-Rad). To detect
the native control protein (BT4657), the blots were washed
overnight in PBS–Tween 20 (1 PBS containing 5% Tween 20)
and reprobed with rabbit anti-BT4657 antibodies (1: 2000) as
primary.
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Immunofluorescence assays
B. thetaiotaomicron WT, BtCDH, and BtCDH FLAG cells
were grown to the exponential phase (A600 of 0.8) in 5 ml of
minimal medium containing 1%CSA from bovine trachea. The
cells were fixed by adding an equal volume of cell culture to a
1 PBS solution containing 3.7% formalin and rocking over-
night at 4 °C. The cells were harvested by centrifugation at
4000 g for 5 min and washed in 5 ml of PBS three times. The
Cells (1 ml) were later incubated in blocking solution (2% goat
serum, 0.02%NaN3 in 1 PBS) overnight at 4 °C while rocking.
The next day cells were harvested by centrifugation at 16,000
g for 1min and incubatedwith primary rabbit anti-BtCDHanti-
bodies (1:1000) for 2 h at room temperature. Another PBSwash
was performed, and secondary goat anti-rabbit IgG (HL)
cross-adsorbed, Alexa Fluor 488 antibodies (Thermo Fisher
Scientific, catalog no. R37116) were added according to the
supplier’s instructions. The cells were rocked for 30 min at
room temperature and later washed two times in 1 PBS. The
final pellet was resuspended in 100 l of PBS alongside 20 M
Hoechst 33342 nuclear stain (Thermo Fisher Scientific, catalog
no. 62249). The samples were mounted on agarose beds (1%
w/v in PBS) in Gene Frames (Thermo Fisher Scientific, catalog
no. AB0576) and visualized on a Zeiss Axio Observer Z1, with a
LSM800 confocal scan head. The images were taken using a
63 (N.A. 1.4) oil immersion lens with 5 scan zoom applied.
Excitation of the Alexa 488 was performed using the 488-nm
laser line, and the reflected light was collected on a GaAsp
detector between 510 and 700 nm through the variable beam
splitter dichroic block. Excitation of the Hoechst was per-
formed using the 405-nm laser line with emission detected
between 400 and 510nm.A z-section of 25 imageswas recorded
with an interval of 0.1 m using Zeiss Zen 2.3 software with
identical settings for all images. Deconvolution was carried out
usingHuygens Professional (Scientific Volume Imaging) before
amaximum intensity projection was carried out within ImageJ.
Whole-cell assays and supernatant analyses
B. thetaiotaomicron WT, BtCDH, and BtCDH FLAG cells
were cultured to exponential phase (A600 of 0.8) in 5 ml of min-
imal medium. The cells (1 ml) were harvested at 4000 g for 5
min and washed once in 1 PBS by centrifuging again at
4000 g for 5min. The cells were then resuspended in 100l of
PBS containing 4% of the GAG substrate. The samples were
incubated overnight for 2 h followed by centrifugation 4000 g
for 5 min. The supernatants (2 l) were then analyzed by TLC.
To test for BtCDH secretion, 10 l of the B. thetaiotaomicron
WT supernatant was analyzed byWestern blotting using poly-
clonal anti-BtCDH antibodies. For this, filtered and unfiltered
aliquots including a 10 concentrated aliquot of the former
were analyzed. Whole cells (10 l) prepared by resuspending
centrifuged cells in 1 ml of PBS were also analyzed alongside
as controls. To confirm extracellular CS degradation during
growth, cells were harvested at exponential phase (16,000  g
for 1 min), and supernatant (8l) was analyzed by TLC. Super-
natants were also analyzed for secreted BtCDH activity. For
this, supernatants were collected at exponential and centri-
fuged at 4000 g for 5 min to remove cells. This was repeated
once, and the supernatants were finally filtered through a
0.2-m syringe cap filter (Pall Life Sciences). For each reaction,
20 l of the supernatant was incubated overnight with 20 l of
40 mg/ml CS substrate. The next day 4 l of each sample was
analyzed by TLC.
Mass spectrometry
After purification of HA oligosaccharides, 200-l fractions
were freeze-dried and dissolved in distilled water. The samples
were diluted 1:10 (v/v) with buffer B (80% acetonitrile, 20% 50
mM ammonium formate in water, pH 4.7), and 2.0 l was
injected onto an LC-MS instrument configuration comprising
a NanoAcquity HPLC system (Waters) and QTof mass spec-
trometer (Impact II, Bruker). Analysis was performed via gra-
dient elution from a ZIC-HILIC (SeQuant, 3.5 m, 200 Å,
150  0.3 mm, Merck) capillary column heated to 35 °C and
flowing at 5 l/min. The elution gradient was as follows; 100%
buffer B for 5min, followed by a gradient to 0%B, 100%buffer A
(50 mM ammonium formate in water, pH 4.7) over 40 min. 10
column volumes of buffer B equilibration was performed
between injections. MS data were collected in positive ion
mode, 50–2000 m/z, with capillary voltage and temperature
settings of 2800 V and 200 °C, respectively, together with a dry-
ing gas flow of 6 liters/min and nebulizer pressure of 0.4 bar.
The resulting MS data were analyzed using Compass Data-
Analysis software (Bruker).
Phylogenetic analyses
Sequences were retrieved from theNCBI database (cut-off
35% identity) from a BlastP search with BtCDH (residues 308–
708) as query. After trimming the N- and C-terminal domains
of unknown function (DUFs), sequences were submitted to the
http://www.phylogeny.fr/ server (37) in “one-click mode” to
generate a phylogenetic tree.
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leron, A., Bonnaffé, D., Driguez, P. A., Descroix, K., Lassalle, G., LeNarvor,
C., Sandström, C., Spillmann, D., and Berteau, O. (2014) Characterization
of glycosaminoglycan (GAG) sulfatases from the human gut symbiont
Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial en-
dosulfatase. J. Biol. Chem. 289, 24289–24303 CrossRef Medline
13. Pudlo, N. A., Urs, K., Kumar, S. S., German, J. B.,Mills, D. A., andMartens,
E. C. (2015) Symbiotic human gut bacteria with variable metabolic prior-
ities for host mucosal glycans. MBio 6, e01282-15 Medline
14. Raghavan, V., and Groisman, E. A. (2015) Species-specific dynamic
responses of gut bacteria to a mammalian glycan. J. Bacteriol. 197,
1538–1548 CrossRef Medline
15. Tuncil, Y. E., Xiao, Y., Porter, N. T., Reuhs, B. L., Martens, E. C., and
Hamaker, B. R. (2017) Reciprocal prioritization to dietary glycans by gut
bacteria in a competitive environment promotes stable coexistence. MBio
8, e01068-17 Medline
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